Vitreous loss during phacoemulsification is relatively common (1–7%).1 Burk et al described the use of intracameral triamcinalone acetonide (TA) for staining vitreous during anterior vitrectomy (AV) in 2003.1 We have routinely used this technique for a number of years.

Triamcinolone has a long history of intraocular use.2 3 A number of reports suggest an increased risk of ocular hypertension/glaucoma after intravitreal use.4

There is a lack of clinical outcome data after TA-aided AV. Here, we report the 3-month outcomes of intraocular pressure (IOP) and visual acuity (VA) in 14 patients with posterior capsular rupture, vitreous loss and triamcinalone-aided AV.

Method

Data were collected over 18 months. Patients who had TA-assisted AV were identified, and VAs and IOP were recorded at 1 day, 1 month and 3 months after surgery. No patients had previous ocular hypertension or …